<code id='9F161F8342'></code><style id='9F161F8342'></style>
    • <acronym id='9F161F8342'></acronym>
      <center id='9F161F8342'><center id='9F161F8342'><tfoot id='9F161F8342'></tfoot></center><abbr id='9F161F8342'><dir id='9F161F8342'><tfoot id='9F161F8342'></tfoot><noframes id='9F161F8342'>

    • <optgroup id='9F161F8342'><strike id='9F161F8342'><sup id='9F161F8342'></sup></strike><code id='9F161F8342'></code></optgroup>
        1. <b id='9F161F8342'><label id='9F161F8342'><select id='9F161F8342'><dt id='9F161F8342'><span id='9F161F8342'></span></dt></select></label></b><u id='9F161F8342'></u>
          <i id='9F161F8342'><strike id='9F161F8342'><tt id='9F161F8342'><pre id='9F161F8342'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:leisure time    Page View:65992
          Illustration of the U.S. made of blue and white lines. -- health tech coverage from STAT
          Adobe

          A group of academic hospitals and technology companies will form a new nonprofit venture to oversee a nationwide network of laboratories to test artificial intelligence tools designed for use in health care.

          The nonprofit will establish the laboratories at Mayo Clinic, Duke, Stanford, and other major universities and institutions around the country. Its goal is to create a system to certify and register AI models, and publish details about their performance before they are widely adopted. The labs are expected to begin operating within the next few months.

          advertisement

          The nonprofit’s launch, unfolding amid rapid innovation and investment in AI, is an attempt at industry self-policing as increasingly powerful — and opaque — algorithmic models begin making their way into medical settings. It is being formed by a group known as the Coalition for Health AI, whose leadership includes technology experts at the academic hospitals that would host the testing labs.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Readout Newsletter: CAR
          Readout Newsletter: CAR

          HyacinthEmpinado/STATWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiote

          read more
          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more

          Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

          GwenPetersen,38,anALSpatient,believesthattherecentfailureofAmylyx'sdrugRelyvriocouldstillteachresear